health - "develop"

Having a mother with Alzheimer's disease may raise a person's risk of developing the dreaded memory-robbing disease, new research suggests.

Researchers have identified the brain mechanism that switches off traumatic feelings associated with bad memories, a finding that could lead to the development of drugs to treat panic disorders.

Measuring a woman's bone mineral density can provide additional information that may help more accurately determine a woman's risk of developing breast cancer .

Middle-aged married people who worry a lot have at least one thing to look forward to: Their risk of eventually developing Alzheimer's disease may be significantly less than carefree people of the same age who ...

With the recent endorsement by the World health Organization and scientists worldwide of adult male circumcision as an important strategy for HIV prevention, there is increased urgency to develop safe and ...

Simple, everyday movements require the coordination of dozens of muscles, guided by the activity of hundreds of motor neurons. Now, researchers have revealed an important step in the process that guides the early development of neurons themselves, as they establish the precise connections between the spinal cord and muscles. This knowledge will help scientists search for drugs to treat diseases that destroy motor neurons, such as amyotrophic lateral sclerosis, or Lou Gehrig's disease.read more

An international team of researchers has identified a gene mutated in Duane syndrome, a common disorder that restricts the movement of the eyes.read more

Seattle Genetics, Inc. (Nasdaq:SGEN) announced that it has initiated a phase I clinical trial of SGN-70, a humanized monoclonal antibody targeting CD70 that is being developed as an investigational therapy for autoimmune diseases. The trial will assess the safety, tolerability and pharmacokinetics of SGN-70 in healthy volunteers.

Hyperthermia is the name given to a variety of heat-related illnesses that can include heat stroke, heat fatigue, heat syncope (sudden dizziness after exercising in the heat), heat cramps and heat exhaustion. Older adults are particularly at risk for developing heat-related illness because the ability to adequately respond to summer heat can become less efficient with age.

Regenerx Biopharmaceuticals, Inc. (Amex:Rgn) (www.regenerx.com) announced today that it has been awarded an additional $136,245 from the U.S. Food and Drug Administration's (FDA's) Office of Orphan Products Development for continued development of its Tβ4 drug candidate (RGN-137) for treatment of patients with Epidermolysis Bullosa (EB), a rare and debilitating skin blistering disorder.